[Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].
Kuboyama
Noboru
N
n_kuboyama@mb5.skk-net.com
Hayashi
Ichiro
I
Yamaguchi
Tadashi
T
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004285:Dogs; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D050112:Imino Pyranoses / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats
D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D050112:Imino Pyranoses; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine